Predicted protein targets (top 2)
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL28871167 | 0.96 | PTGS1 (0.30) | PTGS1PTGS2 | |
| SCHEMBL3294819 | 0.95 | PTGS1 (0.32) | PTGS1PTGS2 | |
| SCHEMBL3300369 | 0.95 | PTGS1 (0.32) | PTGS1PTGS2 | |
| SCHEMBL5880723 | 0.94 | PTGS1 (0.31) | PTGS1PTGS2 | |
| SCHEMBL23061486 | 0.94 | PTGS1 (0.32) | PTGS1PTGS2 | |
| SCHEMBL14715755 | 0.94 | PTGS1 (0.32) | PTGS1PTGS2 | |
| SCHEMBL20478203 | 0.94 | PTGS1 (0.32) | PTGS1PTGS2 | |
| SCHEMBL14715756 | 0.94 | PTGS1 (0.32) | PTGS1PTGS2 | |
| SCHEMBL48916 | 0.94 | PTGS1 (0.32) | PTGS1PTGS2 | |
| SCHEMBL8750873 | 0.93 | PTGS1 (0.30) | PTGS1PTGS2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2013110515-A1 | POLYAMIDE BASED SIZING COMPOSITION FOR GLASS FIBRES | 3B-FIBREGLASS SPRL (BE) | 2013-08-01 | — | — | WO | claimed |
| US-20230071589-A1 | AN ABRASION RESISTANT MULTI-LAYERED COMPOSITE | ELKEM SILICONES SHANGHAI CO., LTD. (CN) | 2023-03-09 | — | — | US | disclosed |
| US-20220119677-A1 | CURABLE SILICONE COMPOSITION WITH A GOOD FLAME RESISTANCE | ELKEM SILICONES SHANGHAI CO., LTD. (CN) | 2022-04-21 | — | — | US | disclosed |
| US-20200361180-A1 | LOW TVOC RELEASE SILICONE COMPOSITE SHEET | ELKEM SILICONES SHANGHAI CO., LTD. (CN) | 2020-11-19 | — | — | US | disclosed |
| CN-105744965-A | Antithrombotic medical devices and methods | 柯惠有限合伙公司 | 2016-07-06 | — | — | CN | disclosed |
| US-9051293-B2 | Process for preparing episulfide compounds | ASAHI KASEI CHEMICALS CORPORATION (JP) | 2015-06-09 | — | — | US | disclosed |
| US-20140107350-A1 | Process for Preparing Episulfide Compounds | ASAHI KASEI CHEMICALS CORPORATION (JP) | 2014-04-17 | — | — | US | disclosed |
| WO-2013110515-A1 | POLYAMIDE BASED SIZING COMPOSITION FOR GLASS FIBRES | 3B-FIBREGLASS SPRL (BE) | 2013-08-01 | — | — | WO | disclosed |
| EP-1376229-A1 | Structure for pattern formation, method for pattern formation, and application thereof | DAI NIPPON PRINTING CO., LTD. (JP) | 2004-01-02 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20140107350-A1 | Process for Preparing Episulfide Compounds | TST, EPHX2, STS | PTGS1 214/4885PTGS2 152/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.